Intellectual Property Archive » January, 2018

Intellectual Property - January, 2018

399 articles

• Teikoku Swears Off Pay-For-Delay In Lidoderm Deal With AGs
• Waymo Trial Is About IP, Not Whether Uber's Evil: Judge
• Disney Dodges 'Inside Out' Copyright Suit For Now
• Axing Restasis Patents Would Stifle Innovation, PhRMA Warns
• NY Comedians Cut Deal To End IP Suit Over TV Show Stunt
• Most Of Porn Co.'s IP Claims Cut From Video Hosting Suit
• Patent Owners Should Think Hard Before Giving Up At PTAB
• Athletes Tell 7th Circ. They're Cards In Online 'Casinos'
• 7th Circ. Overturns Ariel Investments' Trademark Win
• Blind-Maker Hit With Fees For 'Lack Of Respect' For Patent
• FTC Looks To Beat Suit Challenging Its Authority
• Centers Of Influence Are Key To Small Law Firm Rainmaking
• IP Group Of The Year: Mayer Brown
• Ensuring Section 121 Safe Harbor Applies To Patent
• Trump's State Of The Union Breaks Little Ground On Trade
• As Uber-Waymo Trial Nears, Judge Highlights MoFo's Impact
• Life Tech Rips Promega Bid To Rethink US Damages In IP Row
• Honus Wagner Co. Can't Revive Trademark Suit In Fla.
• 'The Girls' Author Says Ex's Copyright Suit Can't Stand
• Indians Sacking 'Wahoo' Logo Puts Squeeze On Redskins
• Fed. Circ. Says PTAB Erred In Axing Part Of Surgical Patent
• Justices Told Fed. Circ.'s 1-Line Orders Unconstitutional
• Russ August Lures Entertainment Pros From DLA Piper
• Nixon Peabody Adds Patent Partners In Los Angeles
• DLA Piper Media Practice Adds 2 Partners In LA
• Ex-Teva Exec Didn't Violate CFAA In Sharing Info With Lover
• U2 Beats Copyright Suit Over Decades-Old Song
• Wrigley Sues Vape Co. Over Starburst, Skittles Flavors
• Samsung, Verizon Face East Texas IP Infringement Suit
• Gems Of Wisdom: A Guide To Protecting Jewelry Designs
• IP Group Of The Year: Finnegan
• Akorn, Fera, Perrigo Settle Trade Secrets, Antitrust Suit
• Cooley Lands MoFo Litigation Ace, Drones Practice Chair
• TC Heartland And Hatch-Waxman: Square Peg In Round Hole
• Electric Car Co. Claims Ex-Execs Stole Trade Secrets, Staff
• Apple Says Voip-Pal Lied About Source Of PTAB Letters
• Nestlé Says Crest Must Pick Up Discovery Pace In IP Fight
• Cleveland Indians To Drop 'Chief Wahoo' Logo From Uniforms
• Universal, Amazon Near TickBox Injunction, But Extent Hazy
• Copyright Board Hikes Streaming Music Royalties
• Patent Deal Clears Actavis' Zohydro Generic For 2029
• 9th Circ. Reverses Whole Foods Win In 'EatRight' TM Row
• From Law Firm To Newsroom: An Interview With Bob Woodruff
• NCAA Sues Over 'Markdown Madness' As Tourney Nears
• Novartis Blasts Attempt To Revive Pay-For-Delay Suit
• 2nd Swipe At 'Secret' USPTO Program Fails At Claims Court
• IP Group Of The Year: Goodwin Procter
• Cozen O'Connor Adds Ex-Lindquist Antitrust Litigator
• Judging A Book: Kendall Reviews 'On The Jury Trial'
• Travel Sentry V. Tropp: A Threat To Direct Infringement?
• Netflix, SAG Weigh In On Opposite Sides In FX 'Feud' Row
• 'We Shall Overcome' In Public Domain, Publisher Agrees
• High Court Denies Helsinn's Bid To Stay On-Sale Bar Ruling
• Redbox Says Disney's Misusing Copyrights, Blocking Sales
• Brand Battles: Warner Bros., Sazerac, Amazon
• 3 Int'l Patent Developments Attys Should Know About
• Mylan Pradaxa Generic Delayed In Boehringer Patent Deal
• US Tax Court Nominee An Expert On Tax-Exempt Matters
• Comcast Defends Hire Of Ex-Tech VP To Consult On IP Suit
• CBS Wins Atty Fees In 'Exceptionally Weak' Patent Suit
• Fed. Circ. Chief Judge Says Oral Args' Value Is 'Cleanup'
• FDA Must Explain Amgen Exclusivity Denial, Judge Rules
• Health Hires: Frost Brown, EBG, McDermott, Dykema Cox
• IP Group Of The Year: Hughes Hubbard
• Treasury Rep Defends TCJA Provision Against OECD Rules
• IP Hires: Blank Rome, Mandelbaum Salsburg, NovoTechIP
• Lenovo, Motorola End Suits By Wi-LAN Over 4G Tech
• New Fed. Circ. Guidance For Patenting Software Inventions
• Trade Secret Law In China: 3 Highlights From 2017
• Music Modernization Act: 4 Big Things You Need To Know
• FDA Lawfully Denied Exclusivity For Namenda Generic: Judge
• Disney, Fox Fight To Toss IP Suit Over Visual Effects
• Fitbit Rival Dodges Sanctions Bid In IP Suit, For Now
• Fed. Circ. Says PTAB Must Reconsider Claims In TV Patent
• Arista's New Antitrust Claims 'Stretch' Court Order: Judge
• Allergan, Restasis Buyers Can't Agree On MDL Venue
• Fed. Circ. Says Display Patents LG Infringed Survive Alice
• Recent PTAB Decisions Attorneys Should Know
• Tech Leaders Worry About DOJ Focus On SEP Licensees
• 'Heart Attack Grill,' 'Heart Attack Shack' Settle TM Beef
• 2nd Circ. Keeps $5M Sanction In Counterfeit Headphones Suit
• Engineer Ducks Prison For Trying To Poach Trading Software
• Do I Need New Trial Counsel? 9 Questions To Ask
• Illumina Wins $27M Prenatal Test IP Verdict Against Ariosa
• Blank Rome Snags Litigation Partner From Pepper Hamilton
• Exmark And The Erosion Of The Entire Market Value Rule
• Groups Warn Against NAFTA Changes That Raise Drug Prices
• A Look At Chemical Supplemental Examination Requests
• Chinese Wind-Turbine Maker Convicted Of Trade Secret Theft
• Investor In Stan Lee Media Company Challenges Merger
• FDA, Endo Freeze High-Stakes Drug Compounding Case
• Texas Man Gets 4 Years For Space Circuit Smuggling Scheme
• PTAB Won't Rehear DOJ's Challenge To E-Passport Patent
• Enrique Iglesias Sues Universal For Streaming Royalties
• ABA, INTA Urge Full Fed. Circ. To Kill USPTO Fee Rule
• Cellular Communications LTE Patent Claims Nixed At PTAB
• Fed. Circ. Upholds PTAB Ruling In Suture Patent Case
• Law Prof Urges US To Have Cos. 'Hack Back' At Cyberthreats
• Grumpy Cat Gets Mad Over IP Coffee Case, Wins $710K
• Senators Push For Big Changes To Music Licensing
• Engineers Charged With Exporting Military Tech To China
• NovoTechIP Adds Former McDermott Partner As Director
• 10 Antitrust Developments And Trends To Watch In 2018
• Allergan Vies For Insurance Coverage Lists In Asacol Trial
• Spencer Fane Adds 2 Ex-JacksonWhite Attys In Phoenix
• Cloud-Based Patent Claims — And How Providers Can Help
• And Now A Word From The Panel: 2017 MDL Year In Review
• Illumina, Ariosa Seek Tens Of Millions As IP Trial Ends
• WARF Urges Fed. Circ. To Uphold $506M Apple Patent Win
• Tapped For Bench, A Look Back At Ohlhausen's Time At FTC
• 1st Circ. 'Reluctantly' Nixes Sanctions In $70M Fine Appeal
• EU Court Backs €183M Fine In Italian Drug Antitrust Case
• 11th Circ. Won't Rehear Online Retailer's Challenge In TM Spat
• Fed. Circ. Backs PTAB's Invalidation Of J&J Remicade Patent
• Attys Who Won Slants Ruling Join Mandelbaum Salsburg
• Ex-Winston Partner Fights Order To Arbitrate Bias Case
• Ex-Sedgwick Bankruptcy Chair Heads To Rimon Calif. Offices
• Swiss Artist Says GM Used Mural In Ad Without Permission
• USPTO Defends Fed. Circ. Patent Test At High Court
• Medline Says TC Heartland Doesn't Apply To Bard Transfer Bid
• Corel Fights Microsoft 'Ambush' On Eve Of Patent Trial
• Scottsdale Off The Hook For Independent Counsel Costs
• The Firms Filing The Most Copyright Suits
• The Firms Filing The Most Trademark Suits
• Fed. Circ. Backs PTAB Denying Google Win In Tagging IP Row
• The Firms Filing The Most Patent Suits
• Israeli Info Crucial To $163M Perrigo Tax Row, IRS Says
• Candy Seller Sugarfina Says Rival Unresponsive In TM Suit
• Lessons From President Trump's Failed Judicial Nominations
• PTAB Lets Honeywell Pursue CBM Patent Challenge
• High Court Considers Upending Patent Damages
• Beware Traps In Advisory Board Agreements
• IP Owners Group Says USPTO Fees Rule Is 'Crippling'
• Fed. Circ. Bats Down Helsinn Bid To Stay On-Sale Bar Ruling
• Rarely Used ITC 100-Day Program Still Has Positive Effect
• Fenwick IP Partner Tapped As Calif. Fed. Magistrate Judge
• Del. Chancellor Expedites IT Firm Board Meeting Suit
• Patent Owners Unclear On Telling Juries About AIA Wins
• Justices Asked To Weigh Patentability Of Natural Processes
• German SEO Firm Wins Patent Infringement Fight Under Alice
• $3.75M Award Over Sale Of 'Daily Mail' URL OK'd
• Fed. Circ. Gives Patentee New Shot After WiFi One Decision
• Lab Owner Never Agreed To Be Face Of Sex Drug, Suit Says
• Nautilus Scores $1.8M In Chinese-Elliptical IP Row Win
• How To Control Data As Technology Complicates E-Discovery
• Sorting Out Single-Reference Obviousness At Fed. Circ.
• Immigration Standoff Keeps Government Shuttered
• Lab's Peptide IP Suit May Run Aground On Safe Harbor
• NCAA Scores Default Victory In Basketball Tourney TM Suit
• Record Cos. Sue Music App Over 'Massive' Infringement
• DOJ Antitrust, FTC Chiefs Signal Continued Focus On IP
• USPTO Floats Patent Regs To Ax Under '1 In, 2 Out' Plan
• Fed. Circ. Gives Patent Damages Experts More Flexibility
• Fed. Circ. OKs Gilstrap Erasing Jury's Invalidity Verdict
• Software Developer Gets 5 Years For Stealing Source Code
• Brand Battles: Green Bay Packers Tackle 'Titletown' TM
• BoingBoing Owner Wants Out Of Playboy's Copyright Suit
• Cornell, Life Tech Must Arbitrate IP Settlement Fight
• Applebees, IHOP Can't Toss TM Suit Over Splenda Knockoff
• An Important Evidentiary Issue In The 'Blurred Lines' Appeal
• Sony, Movie Producer Settle Suit Over 2014 Cyberattack
• Samsonite, Others Urge Fed. Circ. To Rethink Lock IP Ruling
• IP Hires: Akerman, Grant & Eisenhofer, Levi & Snotherly
• Merck Loses Bid To Revive Antibiotic Patent In Fed. Circ.
• Helsinn Wants On-Sale Bar Ruling Held For High Court Appeal
• TTAB Greenlights New Logo For Pitney Bowes
• Fed. Circ. Presens Ruling Provides Insights On Prior Art
• Fox Seeks To Toss 'Gone Girl' Infringement Suit
• GM Says Car Entertainment Systems Not Recording Devices
• Judge Won't Kill Soil Sample App Patent Under Alice
• Janssen Sues Teva To Stop Generic Of Schizophrenia Drug
• Kipling-Quoting Oil Developer Gets No Fees In Patent Case
• Generics Co. Resists Allergan's Bid To Leave Restasis IPRs
• 'Bed-In-A-Box' Patent Ruling Chock-Full Of Flaws: Fed. Circ.
• Courtroom Will Stay Open For Waymo Trade Secrets Battle
• Qualcomm Trims IP From $37.7B NXP Deal For EU Approval
• PTAB Nixes Claims In Half-Pipe Water Ride Patent
• 4th Circ. Formally Tosses Redskins Trademark Ruling
• The Eagles Settle TM Case Over Real-Life Hotel California
• Clarify Alice Rules In Shipping Patent Case, High Court Told
• Tips For Overcoming Unfavorable ITC Initial Determination
• When And How To Use Conjoint Analysis For Patent Damages
• Argentum Wins Invalidation of J&J Unit's Cancer Drug Patent
• Merck, Glenmark Stifled Cholesterol Drug Market, Suit Says
• DraftKings, FanDuel Blast Student-Athlete Appeal In IP Row
• Grant & Eisenhofer Opens IP Practice With Reed Smith Hire
• Live Nation Can't Get PTAB To Review Ticket-Resale Patent
• PTAB 'Printed Publication' Scrutiny Can Trip Up Challengers
• ITC To Review Ruling Freeing Apple From Audio Patent Claim
• Chamber Backs GSK In 3rd Circ. Flonase Rehearing Bid
• Mercedes-Benz Settles QR Code Patent Suit
• MGM Wants Fees After Magazine's 'Baseless' Trademark Suit
• Court Couldn't Hear Firm's Trademark Case, 7th Circ. Told
• Author Says Texas A&M Athletics Can't Avoid Copyright Suit
• Hep C Meds Patent Row Can't Stay In Minn., Fed. Circ. Says
• Redbox Calls Disney Copyright Suit 'Anti-Competitive'
• Drugmaker Urges Full Fed. Circ. To Kill USPTO Fee Rule
• IPR Appeals In 2017: The Outcomes In Remands To PTAB
• A Chat With Davis Wright CSO Mark Usellis
• Oil States Patent Dispute Will Affect Bankruptcy Courts
• High Court Case Could Open New World Of Patent Damages
• Fed. Circ. Revives Bid To Bar L'Oreal Products In IP Row
• Fed. Circ. Clarifies But Won't Redo AIA On-Sale Bar Ruling
• Uber Slams Waymo's Hidden-Evidence Claims As 'Whining'
• Voip-Pal Says Apple's Sanctions Bid At PTAB 'Absurd'
• Fed. Circ. Affirms Patent Win For 'Warcraft' Maker, Others
• PTAB Nixes Sipco Wireless Communication Patent Under Alice
• Allergan Deal Clears 2031 Launch Of Sun's Linzess Generic
• Purdue's 'Duplicative' Suit Over OxyContin Generic Gets Ax
• Akerman Hires Ex-Sedgwick IP Media Duo In LA
• High Court Won't Consider Atty Fees In Medtronic Case
• Starbucks Wins EU Ruling Over 'Coffee Rocks' Trademark
• IPR Appeals In 2017: The Pendency And Success Rates
• A Definiteness Reminder For Pharmaceutical Patent Drafters
• Patent Cases Dwindled And Shifted Away From EDTX In 2017
• The Firms That Dominated In 2017
• Law360 Names Practice Groups Of The Year
• Fed. Circ. Junks Exmark's $24M Lawn Mower Patent Trial Win
• Live Nation Settles Songkick Antitrust Suit In $110M Deal
• Hard Rock Injunction Bid In TM Suit Too Sweeping, Co. Says
• Fed. Circ. OKs Denial Of Attys Fees In Honeywell Patent Row
• Tribe Says Immunity Unscathed By Joining Allergan IP Suit
• Brand Battles: James Bond, NFL, Marriott, Delta
• PTAB To Review Tyvaso Patents Despite Time-Bar Protest
• Fed. Circ. Says SAP Can't Get Fees In Patent Case
• Ericsson Ruling Provides Guidance On FRAND Royalty Rates
• Lucrative Piracy Hotspots Named In USTR Report
• Raytheon Mischaracterized Trade Secrets, Fed. Circ. Told
• FanDuel Latest To Face Cloud Computing Patent Suit
• Justices To Hear Patent Case Over Lost Profits Damages
• Ex-VP Can't Help Comcast In IP Row, Tech Firm Says
• Ex-McKool Smith Atty, Samsung Director Open ITC Firm In DC
• A Survey Of In-House Attorney Views On Trade Secrets
• IP Hires: Freeborn, McKool Smith, Womble Bond
• 5 Advertising Law Trends To Watch In 2018
• TiVo Launches 2 More Patent Suits In Comcast IP Battle
• Fed. Circ. Keeps UPS' Alice Win On Notification Patent
• Samsung Scolded For Continued Phone Sales In Apple Row
• Freeborn Snags Vedder Price Atty For Its Chicago IP Team
• Suing Models Seek To Freeze Assets Of Fla. Swingers Club
• PTAB Labels 2 Decisions As Guidelines On Time-Bar Rulings
• Water Balloon Toy Makers Square Off Over IP In Fed. Circ.
• Restasis Is FDA-Approved, Allergan Reminds Compounder
• Change To Local Rules May Bring More Patent Cases To Mass.
• 1st Circ. Chides Biolitec For Umpteenth Appeal Of $70M Fine
• Fed. Circ. Upholds Nix Of Patent Suit Against HTC, Motorola
• Studios Expand Streaming Device War With Dragon Box Suit
• Amgen, Genentech Await Del. Ruling In Biosimilar IP Row
• Google Says IP Suit Over Messaging Repeats Axed Claims
• DQ King & Spalding In Vaccine Patent Row, Ex-Client Says
• Army Fights Trademarks For NHL's Vegas Golden Knights
• Martin Luther King Jr. And Copyright: 5 Things To Know
• Novartis' Zortress Patent Survives PTAB Challenge
• 6 E-Discovery Predictions For 2018
• Murky FDA Device Guidance Kills Sanofi Antitrust Suit
• TCL Seeks To Reduce Ericsson's $75M Patent Win
• Ex-Commerce Official Billed Gov't For Cabs, Report Says
• The Latest Fed. Circ. Approach To 'Inference Of Intent'
• Ed Sheeran, Tim McGraw Stole Hit Song, Suit Says
• Multidistrict State Venue Issue Prompts Fed. Circ. Sparring
• 6th Circ. Revives TM Suit Over Gun Scope Grip
• Judge Says Apple, Qualcomm Should Face Patent Suit In Fla.
• Google Says Wi-Fi One Supports High Court Bid In CBM Case
• Iowa Settles Free Speech Case Over Student Pot T-Shirts
• Former Loeb & Loeb Client Says Firm Misfiled Patent Notices
• Auctioneer Fights Domain Name Transfer To Augusta National
• Kohler Says Competitor's Products Infringe Sink Patent
• Allergan's Restasis Patents Are Valid, Fed. Circ. Told
• Facebook, Feds Narrow Dispute Over IRS Summonses
• Fed. Circ. Upholds Facebook's Alice Win On Database Patent
• What Is A 'Place Of Business'? Here's What We Know Now
• Ex-Water Splash Employee Wins Appeal In Hague Service Row
• Fed. Circ. Ruling Prompts Mistrial In Symantec Unit IP Case
• Fed. Circ. Continues To Rein In PTAB
• Fed. Circ. Upholds Samsung's PTAB Win Over Eye Sensor IP
• Crib Maker Struggles To Nix Rival's Patent At Fed. Circ.
• Simmons Nabs Ex-CMS London Atty For New Patent Group
• Law360's Pay-For-Delay Case Cheat Sheet For 2018
• The Trouble With Trademarking A Trend
• 6 Roles To Embrace In An Evolving Legal Industry
• Finjan CEO Says Paid Verdict Didn't Earn Blue Coat IP Rights
• IP Firm Stakes Survival On War Against Non-Atty TM Services
• Ariosa, Illumina Spar Over Patent Timing In DNA Test Trial
• PTAB Bungled 'Average' Battery Output Claims, Fed. Circ. Told
• 11th Circ. Says Commodores Founder Can't Use Band's Marks
• IBM Nabs 9,000 US Patents In 2017, An All-Time Record
• Fed. Circ. Urged In UPS Row To Revive Telecom Tech IP
• Allergan Wants Out Of Restasis Patent Challenges
• Perrigo Fights Deposition Of Dexcel Workers In $163M Bout
• Copyright Conundrum: Anatomy Of A Circuit Split
• Apotex Gets PTAB To Trim OSI's Cancer Drug Patent
• Fed. Circ. ​Ruling May Trigger New Wave Of TM Applications
• Ticketmaster Says Scalpers Can't Duck Bot-Buying Claims
• Aggrenox End-Payors Reach $54M Deal In Pay-For-Delay Suit
• Ex-USPTO Director Lee Says She Did Not Stack PTAB Panels
• NYC Seeks Quick Win In Tavern On The Green TM Suit
• Hagens Berman, Others Want $31M In Pfizer Celebrex Deal
• This Year, Let's Invest In Lawyer Resiliency
• Amici Views On Big Pharma 'Renting' Sovereign Immunity
• Finjan Says Symantec Unit Owes $30M In IP Trial Rematch
• Fox Factory Patent Suits Moved From Calif. To Colo.
• High Court Declines To Review 7 IP Cases
• Fed. Circ. Ruling Clears Way For More PTAB Appeals
• Genomics IP Trial Between Illumina And Ariosa Kicks Off
• Endo Gets OK To Join FTC's Impax Pay-For-Delay Case
• Allergan Fights To Keep Live Testimony In Asacol Trial
• Firm Fighting Equinox In TM Spat Defends False Ad Claims
• Supreme Court Declines To Rehash Stryker Noncompete Win
• 9th Circ. Mostly Sides With Oracle In Rimini Copyright Suit
• GSK Wants 3rd Circ. To Rehear La. Flonase Decision
• Louis Vuitton Should Lighten Up, But Not Pay Fees: Judge
• CSL Must Face Shire's Willful Infringement Claim
• 5 Legal Technology Predictions For 2018
• Restasis Antitrust Suits Paused For MDL Panel Review
• Womble Bond Adds Ex-Taylor English Patent Pro In Atlanta
• McKool Smith Nabs Former ITC Commissioner For DC Office
• Justices Want SG's View On Circuit Split Over Copyright
• Indirect Purchaser Cases In 2017: Key District Court Rulings
• New USPTO Fees Likely To Attract More Chinese Applicants
• Full Fed. Circ. Rules PTAB Time-Bar Rulings Are Appealable
• Ding! Ding! Ding! Video Doorbell Knocks Rival In IP Suit
• Health Co. Hit With Erection Illustration Copyright Suit
• Judge Calls Samsung Bid For Apple Data 'Desperation Heave'
• Apple Hit With $300K Sanction In Qualcomm Antitrust Row
• PTAB Scolds Tribe Over Unauthorized Impartiality Motion
• Covidien Nears OK For Stay Of California IP Suit
• Fed. Circ. Affirms DuPont Win In Monsanto Patent Re-Exam
• Brand Battles: BuzzFeed's 'Wordy Wine' Hits Trademark Snag
• Court Divide Could Spur More Hatch-Waxman Venue Fights
• Fed. Circ.'s 2017 Patent Decisions: A Statistical Analysis
• Insomnia Cookies Hits Snooze On Trademark Spat
• Good News For Trade Secret Actions At ITC
• Law Profs Urge Supreme Court To Abolish Assignor Estoppel
• Hyundai, VW Reach Deals With Driverless Car Startup
• 4 Things To Know About The Latest FRAND Rate-Setting Case
• Full 2nd Circ. Pressed To Review Louis Vuitton TM Suit
• Facebook Won't Get $15M Bond Before Trade Secrets Trial
• Transposagen Can't Use TC Heartland To Nix Antibody IP Suit
• TTAB Rejects 'Crossbox' As Too Similar To 'CrossFit'
• Waymo Must Show Uber Used IP, Judge Aims To Tell Jury
• TerraVia Holdings Moves Ahead With Ch. 11 Liquidation
• TTAB Says Sailboat Logo Is Confusingly Similar To Nautica's
• Allergan Announces Reduction Of 1,000 Jobs
• ITC To Probe IPhones After Qualcomm Patent Complaint
• Fed. Circ. Revives Infringement Row Over Pill Coating
• Celgene Hits Supplier With Cancer Drug Trademark Suit
• Apple Calls $25K Daily Sanctions In Qualcomm Case Harsh
• Fed. Circ. Affirms Jury Invalidation Of Nichia LED Patents
• Taylor Swift Seeks To Shake 'Shake It Off' Copyright Suit
• PTAB Declines To Review Oft-Challenged LED Patent
• Arctic Cat, Bombardier Vie For Do-Overs On Patent Verdict
• Continuing Uncertainty On Scope Of IPR Petitioner Estoppel
• Litigation Finance Trends To Watch In 2018
• New Year's IP Resolutions For Companies
• Shire, Ultragenyx Settle Row Over 'Trade Secret' Doctor List
• 3rd Circ. Backs Nix Of Pharmacies' Claim In Lipitor MDL
• ZTE Settles In Multi-Defendant Cellphone Patent Suit
• Mohawk Tribe Demands Info On 'Impartiality' Of PTAB Judges
• Qualcomm Rips Magistrate's Venue Change Report In IP Row
• TTAB Says 'Donq' Not Related To Rum Brand Don Q
• FDA Unveils Guidance To Smooth Generic-Drug Path
• Kia Didn't Infringe Allstate Trademark, Judge Says
• The Enneagram And The Practice Of Law
• JPMorgan Sues Patent Firm In Del. For $69M Refund
• Alissa Starzak On Net Neutrality, US Army, Leap To Startup
• Amgen Says It Didn't Mislead On Biosimilar Marketing Date
• Honus Wagner Co. Seeks Redo In Licensing Dispute
• PTAB Deals A Crippling Blow To Sovereign Immunity
• Facebook Agrees To Mediate Search Patent Suit
• Will ITC Become The Forum Of Choice For Patent Litigation?
• 9th Circ. Refuses To Rehear Record Co.'s 'Empire' TM Suit
• Chicago Photographer's Estate Sues French Gallery Over IP
• Medical E-Records Co. Files $30M Suit Against Rival
• La-Z-Boy Reaches $13.5M Settlement In Footrest Patent Case
• Cleaning Biz's Trademark Suit Coverage Bid Scrubbed Out
• Novelis Slams Arconic's Trade Secrets Claims
• Quinn Emanuel Set To Launch New Boston Office
• Tom Petty Publisher Hits Spotify With $1.6B IP Suit
• Phoenix Comicon Changes Name Amid San Diego TM Fight
• Sloan Kettering Gets Trimmed Fees In IP Fight
• Fed. Circ. Won't Rehear Appeal In Data-Mining Patent Row
• Lupin, Sandoz Settle With Retailers In Solodyn Suit
• Fed. Circ. Asked To Clarify Venue For Multidistrict States
• Mitsubishi Data Storage Unit Sued Over Blu-Ray Disc IP
• IRS Knocks Whitney Houston's $11M Tax Bill Down To $2.3M
• Sports Psychologist, Football Coach End Retweet IP Fight
• Waymo Says Withheld Letter Could Be Uber 'Cover-Up'
• IBM Sues Expedia, Orbitz On Patent Infringement Claims
• Judging A Book: Tymkovich Reviews 'Gorsuch'
• Capital One Seeks To Revive Banking-Tech Monopoly Claims
• 'Posh' Manhattan Bar Sues 'Basic' NC Spot Over Name
• The Hottest Patent Law Issues Of 2017
• Copyright Cases To Watch In 2018
• Trademark Cases To Watch In 2018
• Life Sciences Cases To Watch In 2018
• Native American Cases To Watch In 2018
• California Cases To Watch In 2018
• Patent Litigation Trends To Watch In 2018
• Patent Cases To Watch In 2018